LBX Pharmacy Chain Joint Stock Company (603883.SS)
CNY 18.03
(-1.04%)
CNY 18.03
(-1.04%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 9.86 Billion CNY | 80.76% |
| 2022 | 5.45 Billion CNY | -9.45% |
| 2021 | 6.02 Billion CNY | 361.78% |
| 2020 | 1.3 Billion CNY | -29.42% |
| 2019 | 1.84 Billion CNY | 8.3% |
| 2018 | 1.7 Billion CNY | 58.86% |
| 2017 | 1.07 Billion CNY | -15.6% |
| 2016 | 1.27 Billion CNY | 1112.58% |
| 2015 | 105 Million CNY | -69.68% |
| 2014 | 346.31 Million CNY | 9.96% |
| 2013 | 314.93 Million CNY | 65.75% |
| 2012 | 190 Million CNY | -9.52% |
| 2011 | 210 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 2.92 Billion CNY | -48.29% |
| 2024 Q2 | 9.61 Billion CNY | -0.1% |
| 2024 Q1 | 9.62 Billion CNY | -2.4% |
| 2023 Q4 | 9.86 Billion CNY | 72.02% |
| 2023 Q1 | 5.32 Billion CNY | -2.32% |
| 2023 Q2 | 5.53 Billion CNY | 3.85% |
| 2023 Q3 | 5.73 Billion CNY | 3.59% |
| 2023 FY | 9.86 Billion CNY | 80.76% |
| 2022 Q4 | 5.45 Billion CNY | -10.0% |
| 2022 Q3 | 6.06 Billion CNY | 9.05% |
| 2022 Q2 | 5.55 Billion CNY | 2.04% |
| 2022 Q1 | 5.44 Billion CNY | -9.58% |
| 2022 FY | 5.45 Billion CNY | -9.45% |
| 2021 Q2 | 4.19 Billion CNY | 2.56% |
| 2021 Q3 | 4.4 Billion CNY | 4.96% |
| 2021 Q4 | 6.02 Billion CNY | 36.71% |
| 2021 FY | 6.02 Billion CNY | 361.78% |
| 2021 Q1 | 4.09 Billion CNY | 213.78% |
| 2020 Q2 | 1.9 Billion CNY | -14.49% |
| 2020 Q3 | 1.53 Billion CNY | -19.17% |
| 2020 Q4 | 1.3 Billion CNY | -15.05% |
| 2020 FY | 1.3 Billion CNY | -29.42% |
| 2020 Q1 | 2.22 Billion CNY | 20.21% |
| 2019 Q3 | 1.28 Billion CNY | -37.97% |
| 2019 Q1 | 1.71 Billion CNY | 0.27% |
| 2019 Q2 | 2.07 Billion CNY | 21.04% |
| 2019 FY | 1.84 Billion CNY | 8.3% |
| 2019 Q4 | 1.84 Billion CNY | 43.87% |
| 2018 Q1 | 1.06 Billion CNY | -0.68% |
| 2018 Q4 | 1.7 Billion CNY | 10.77% |
| 2018 Q3 | 1.54 Billion CNY | 22.25% |
| 2018 Q2 | 1.26 Billion CNY | 18.12% |
| 2018 FY | 1.7 Billion CNY | 58.86% |
| 2017 Q4 | 1.07 Billion CNY | -27.58% |
| 2017 Q1 | 1.26 Billion CNY | -0.62% |
| 2017 Q2 | 1.38 Billion CNY | 9.33% |
| 2017 Q3 | 1.48 Billion CNY | 7.26% |
| 2017 FY | 1.07 Billion CNY | -15.6% |
| 2016 Q2 | 432.7 Million CNY | 76.61% |
| 2016 Q4 | 1.27 Billion CNY | 57.68% |
| 2016 Q3 | 807.48 Million CNY | 86.62% |
| 2016 Q1 | 245 Million CNY | 133.33% |
| 2016 FY | 1.27 Billion CNY | 1112.58% |
| 2015 Q4 | 105 Million CNY | 2000.0% |
| 2015 FY | 105 Million CNY | -69.68% |
| 2015 Q1 | 315.04 Million CNY | -9.03% |
| 2015 Q2 | 5 Million CNY | -98.41% |
| 2015 Q3 | 5 Million CNY | 0.0% |
| 2014 FY | 346.31 Million CNY | 9.96% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q3 | 356.07 Million CNY | 0.0% |
| 2014 Q4 | 346.31 Million CNY | -2.74% |
| 2013 FY | 314.93 Million CNY | 65.75% |
| 2012 FY | 190 Million CNY | -9.52% |
| 2011 FY | 210 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 326.9 Million CNY | -2916.805% |
| Jointown Pharmaceutical Group Co., Ltd | 38.76 Billion CNY | 74.561% |
| Yifeng Pharmacy Chain Co., Ltd. | 10.05 Billion CNY | 1.919% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 3.69 Billion CNY | -166.839% |